Neuromuscular Diseases Clinical Trial
Official title:
Impact of the Type of Interface in Neuromuscular Patients Treated With Nocturnal Noninvasive Ventilation: a Randomized Crossover Trial
Nocturnal Non Invasive Ventilation (NIV) is the reference treatment for chronic alveolar
hypoventilation in patients with neuro-muscular diseases. NIV can be provided by using
different types of interfaces: Nasal masks are the most frequent type of interface used at
home but oronasal masks are used by at least 25% of neuro-muscular patients mainly because of
persistent unintentional mouth leaks. However, oronasal mask may cause persistent upper
airway obstructive respiratory events because of the mechanical constraint on the chin
induced by the traction of the straps that may push the mandible posteriorly during sleep.
No randomized study has specifically addressed the question of the impact of type of
interface in patients with neuromuscular diseases treated by nocturnal NIV.
The investigators hypothesize that:
1. the application of oronasal mask may jeopardize the pharyngeal patency in patients
already proned to upper airway obstruction;
2. the use of a nasal mask may improve upper airway stability and NIV efficacy while
reducing side effects.
Authors objective will be to compare the impact of nasal mask versus oronasal mask on NIV
efficacy and side-effects. Eligible patients are those with nocturnal NIV and neuromuscular
disease.
After a scheduled hospital visit, patients willing to participate will undergo in random
order 2 unattended nocturnal polygraphies under NIV at home: one polygraphy with nasal mask;
one with an oronasal mask. Each polygraphy ans side effects assessment will be performed
after one week of familiarization with each mask.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
Completed |
NCT04435093 -
Digitalization Playful Module of Motor Function Measure Assessment for Children With Neuromuscular Disorders, MFM-Play Pilot Study.
|
||
Not yet recruiting |
NCT04089696 -
Validation of the "ExSpiron©" in Patients With ALS
|
N/A | |
Not yet recruiting |
NCT05785546 -
Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
|
||
Completed |
NCT01313325 -
Hippotherapy to Improve the Balance of Children With Movement Disorders
|
N/A | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Active, not recruiting |
NCT05070624 -
The Peer Support Study
|
N/A | |
Completed |
NCT04729920 -
Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases
|
||
Recruiting |
NCT04581577 -
Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
|
||
Completed |
NCT06428864 -
Effect of the Use of a 3D Scanner Application on a Smartphone to Mold Garchois Orthotic Device in Neuromuscular Diseases Patients With Scoliosis
|
||
Enrolling by invitation |
NCT05539456 -
Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
|
||
Completed |
NCT05353738 -
Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy
|
||
Recruiting |
NCT04541602 -
Detection of Neuromuscular Complications in Critically Ill Patients
|
||
Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|
||
Enrolling by invitation |
NCT05099107 -
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
|
N/A | |
Completed |
NCT05070910 -
NDT Effectiveness Study
|
N/A | |
Recruiting |
NCT04100993 -
Multisystem and Autonomic Complications of NMD on Long-term NIV
|
||
Recruiting |
NCT04986059 -
Effects of Pre-event Massage on Muscle Activity
|
N/A | |
Completed |
NCT01022931 -
Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
|
N/A | |
Terminated |
NCT03353064 -
Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure
|
N/A |